Percentage of blood samples with tenofovir detected (%) HIV protection efficacy in randomized comparison (%)
Partners PrEP[38] FTC/TDF arm 81 75
TDF2[37] 79 62
iPrEx[34] 51 44
FEM-PrEP[35] 26 6
Table 2: Adherence as Evaluated by Blood Concentrations and Efficacy in PrEP Trials.
Goto home»